UTHR:NASDAQ
United Therapeutics Corp
$503.86
arrow_downward
-0.58%(-2.96) 1D
$503.86
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$502.44
High
$509.79
Low
$497.91
Mkt. cap
21.61B
Avg. vol.
544.00K
Volume
0.00
P/E ratio
18.02
52-wk high
$609.35
52-wk low
$395.23
EPS
$27.96
Beta
0.56
Shares outstanding
42.89M
No. of employees
1K
Open
$502.44
High
$509.79
Low
$497.91
Mkt. cap
21.61B
Avg. vol.
544.00K
Volume
0.00
P/E ratio
18.02
52-wk high
$609.35
52-wk low
$395.23
EPS
$27.96
Beta
0.56
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
Yahoo Finance
·
9 hours ago
United Therapeutics (UTHR) Sets $477.6 Million Buyback. Can Pipeline Funding Keep Pace?
Stock Titan
·
12 hours ago
United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan
Zacks
·
15 hours ago
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio?
Simply Wall Street
·
1 day ago
Is United Therapeutics (UTHR) A Bargain Following Its Tyvaso FDA Acceptance?
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com